Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China

Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of gynecology and obstetrics 2021-08, Vol.304 (2), p.567-569
Hauptverfasser: Chang, Tianli, Song, Su, Huang, Donghui, Su, Ping, Xiao, Xianjin, Li, Honggang, Liao, Aihua, Xiang, Wenpei
Format: Artikel
Sprache:eng
Schlagworte:
China - epidemiology
Correspondence
COVID-19
Disease Outbreaks
Endocrinology
Gynecology
Human Genetics
Humans
Immunotherapy - adverse effects
Lymphocytes
Medicine
Medicine & Public Health
Obstetrics/Perinatology/Midwifery
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 569
container_issue 2
container_start_page 567
container_title Archives of gynecology and obstetrics
container_volume 304
creator Chang, Tianli
Song, Su
Huang, Donghui
Su, Ping
Xiao, Xianjin
Li, Honggang
Liao, Aihua
Xiang, Wenpei
description
doi_str_mv 10.1007/s00404-020-05829-3
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7778486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2550951189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-1ddf551bd606738544a6f7a6f3e7deedb38c1396f632e144511c989203201b493</originalsourceid><addsrcrecordid>eNp9kUtP3TAQha2qFdwCf4AFstRNF00ZPxLbm0rVbaFISCDxWlpO4pDQxE7tpFL-Pb5cSh-LLizb8jdnzvggdEjgIwEQxxGAA8-AQga5pCpjr9CKcEYzEIS8RitQmzMUYhe9jfEBgFApix20yxiTCpRYocsr09hpwb7B_TKMra-WyUbcDcPs_NTaYMYF13Po3D1OV7y-uD37khGF_TyVwZrvuHP4bm6N-4DXbefMPnrTmD7ag-d9D92cfL1ef8vOL07P1p_Ps4rTfMpIXTd5Tsq6SPaYzDk3RSPSYlbU1tYlkxVhqmgKRi3hPCekUlJRYBRIyRXbQ5-2uuNcDraurJuC6fUYusGERXvT6b9fXNfqe_9TCyEkl0USeP8sEPyP2cZJD12sbN8bZ_0cNeUiTx-YWif03T_og5-DS-NpmicomZMbR3RLVcHHGGzzYoaA3gSmt4HpFJh-CkyzVHT05xgvJb8SSgDbAnHchGDD797_kX0E2SKftA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2550951189</pqid></control><display><type>article</type><title>Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Chang, Tianli ; Song, Su ; Huang, Donghui ; Su, Ping ; Xiao, Xianjin ; Li, Honggang ; Liao, Aihua ; Xiang, Wenpei</creator><creatorcontrib>Chang, Tianli ; Song, Su ; Huang, Donghui ; Su, Ping ; Xiao, Xianjin ; Li, Honggang ; Liao, Aihua ; Xiang, Wenpei</creatorcontrib><identifier>ISSN: 0932-0067</identifier><identifier>EISSN: 1432-0711</identifier><identifier>DOI: 10.1007/s00404-020-05829-3</identifier><identifier>PMID: 33389097</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>China - epidemiology ; Correspondence ; COVID-19 ; Disease Outbreaks ; Endocrinology ; Gynecology ; Human Genetics ; Humans ; Immunotherapy - adverse effects ; Lymphocytes ; Medicine ; Medicine &amp; Public Health ; Obstetrics/Perinatology/Midwifery ; SARS-CoV-2</subject><ispartof>Archives of gynecology and obstetrics, 2021-08, Vol.304 (2), p.567-569</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c425t-1ddf551bd606738544a6f7a6f3e7deedb38c1396f632e144511c989203201b493</cites><orcidid>0000-0001-9510-116X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00404-020-05829-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00404-020-05829-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33389097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Tianli</creatorcontrib><creatorcontrib>Song, Su</creatorcontrib><creatorcontrib>Huang, Donghui</creatorcontrib><creatorcontrib>Su, Ping</creatorcontrib><creatorcontrib>Xiao, Xianjin</creatorcontrib><creatorcontrib>Li, Honggang</creatorcontrib><creatorcontrib>Liao, Aihua</creatorcontrib><creatorcontrib>Xiang, Wenpei</creatorcontrib><title>Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China</title><title>Archives of gynecology and obstetrics</title><addtitle>Arch Gynecol Obstet</addtitle><addtitle>Arch Gynecol Obstet</addtitle><subject>China - epidemiology</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>Disease Outbreaks</subject><subject>Endocrinology</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Immunotherapy - adverse effects</subject><subject>Lymphocytes</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>SARS-CoV-2</subject><issn>0932-0067</issn><issn>1432-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtP3TAQha2qFdwCf4AFstRNF00ZPxLbm0rVbaFISCDxWlpO4pDQxE7tpFL-Pb5cSh-LLizb8jdnzvggdEjgIwEQxxGAA8-AQga5pCpjr9CKcEYzEIS8RitQmzMUYhe9jfEBgFApix20yxiTCpRYocsr09hpwb7B_TKMra-WyUbcDcPs_NTaYMYF13Po3D1OV7y-uD37khGF_TyVwZrvuHP4bm6N-4DXbefMPnrTmD7ag-d9D92cfL1ef8vOL07P1p_Ps4rTfMpIXTd5Tsq6SPaYzDk3RSPSYlbU1tYlkxVhqmgKRi3hPCekUlJRYBRIyRXbQ5-2uuNcDraurJuC6fUYusGERXvT6b9fXNfqe_9TCyEkl0USeP8sEPyP2cZJD12sbN8bZ_0cNeUiTx-YWif03T_og5-DS-NpmicomZMbR3RLVcHHGGzzYoaA3gSmt4HpFJh-CkyzVHT05xgvJb8SSgDbAnHchGDD797_kX0E2SKftA</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Chang, Tianli</creator><creator>Song, Su</creator><creator>Huang, Donghui</creator><creator>Su, Ping</creator><creator>Xiao, Xianjin</creator><creator>Li, Honggang</creator><creator>Liao, Aihua</creator><creator>Xiang, Wenpei</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9510-116X</orcidid></search><sort><creationdate>20210801</creationdate><title>Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China</title><author>Chang, Tianli ; Song, Su ; Huang, Donghui ; Su, Ping ; Xiao, Xianjin ; Li, Honggang ; Liao, Aihua ; Xiang, Wenpei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-1ddf551bd606738544a6f7a6f3e7deedb38c1396f632e144511c989203201b493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>China - epidemiology</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>Disease Outbreaks</topic><topic>Endocrinology</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Immunotherapy - adverse effects</topic><topic>Lymphocytes</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Tianli</creatorcontrib><creatorcontrib>Song, Su</creatorcontrib><creatorcontrib>Huang, Donghui</creatorcontrib><creatorcontrib>Su, Ping</creatorcontrib><creatorcontrib>Xiao, Xianjin</creatorcontrib><creatorcontrib>Li, Honggang</creatorcontrib><creatorcontrib>Liao, Aihua</creatorcontrib><creatorcontrib>Xiang, Wenpei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Tianli</au><au>Song, Su</au><au>Huang, Donghui</au><au>Su, Ping</au><au>Xiao, Xianjin</au><au>Li, Honggang</au><au>Liao, Aihua</au><au>Xiang, Wenpei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China</atitle><jtitle>Archives of gynecology and obstetrics</jtitle><stitle>Arch Gynecol Obstet</stitle><addtitle>Arch Gynecol Obstet</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>304</volume><issue>2</issue><spage>567</spage><epage>569</epage><pages>567-569</pages><issn>0932-0067</issn><eissn>1432-0711</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33389097</pmid><doi>10.1007/s00404-020-05829-3</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-9510-116X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0932-0067
ispartof Archives of gynecology and obstetrics, 2021-08, Vol.304 (2), p.567-569
issn 0932-0067
1432-0711
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7778486
source MEDLINE; Springer Nature - Complete Springer Journals
subjects China - epidemiology
Correspondence
COVID-19
Disease Outbreaks
Endocrinology
Gynecology
Human Genetics
Humans
Immunotherapy - adverse effects
Lymphocytes
Medicine
Medicine & Public Health
Obstetrics/Perinatology/Midwifery
SARS-CoV-2
title Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T17%3A18%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20of%20lymphocytes%20immunotherapy%20during%20the%20COVID-19%20outbreak%20in%20Wuhan,%20China&rft.jtitle=Archives%20of%20gynecology%20and%20obstetrics&rft.au=Chang,%20Tianli&rft.date=2021-08-01&rft.volume=304&rft.issue=2&rft.spage=567&rft.epage=569&rft.pages=567-569&rft.issn=0932-0067&rft.eissn=1432-0711&rft_id=info:doi/10.1007/s00404-020-05829-3&rft_dat=%3Cproquest_pubme%3E2550951189%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2550951189&rft_id=info:pmid/33389097&rfr_iscdi=true